Intracellular cancer target screening specialist Curve Therapeutics Ltd has closed a £40.5m financing led by Pfizer Ventures to advance its preclinical pipeline of small cyclic petides.
https://european-biotechnology.com/wp-content/uploads/2024/04/Curve_Therapeutics.png394597Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-02-27 11:11:592024-06-13 14:41:45Curve Therapeutics raises £40.5m in Series A financing